Table 1.
Available baseline demographic characteristics of multiple myeloma (MM) patients whose samples were analyzed in this study
| Characteristics | Cases, n | E2F1‐high, n (%) | P ‡ |
|---|---|---|---|
| All | 59 | 21 (35.6) | |
| Gender† | |||
| Male | 22 | 5 (22.7) | 0.23 |
| Female | 23 | 9 (39.1) | |
| Age† | |||
| <65 | 27 | 11 (40.7) | 0.17 |
| ≥65 | 15 | 3 (20.0) | |
| Type of myeloma† | |||
| IgG | 17 | 6 (35.3) | 0.44 |
| IgA | 13 | 4 (30.8) | |
| IgD | 0 | ||
| IgM | 0 | ||
| Light chain | 13 | 7 (53.8) | |
| Nonsecretory | 0 | ||
| ISS stage† | |||
| I | 3 | 0 (0.0) | 0.02 |
| II | 16 | 4 (25.0) | |
| III | 20 | 13 (65.0) | |
| Patients for immunofluorescence analysis | |||
| Gender | |||
| Male | 5 | 1 (20.0) | 0.14 |
| Female | 8 | 5 (62.5) | |
| Age | |||
| <65 | 9 | 5 (55.6) | 0.51 |
| ≥65 | 3 | 1 (33.3) | |
| Type of myeloma | |||
| IgG | 6 | 3 (50.0) | 0.51 |
| IgA | 5 | 1 (20.0) | |
| IgD | 0 | ||
| IgM | 0 | ||
| Light chain | 2 | 2 (100) | |
| Nonsecretory | 0 | ||
| ISS stage | |||
| I | 1 | 0 (0.0) | 0.02 |
| II | 6 | 1 (16.7) | |
| III | 6 | 5 (83.3) | |
†Information of some patients was not available. ‡Chi‐sqaure test.